JBCHEPHARM — J B Chemicals and Pharmaceuticals Cashflow Statement
0.000.00%
- IN₹249.15bn
- IN₹245.85bn
- IN₹34.84bn
- 100
- 12
- 64
- 64
Annual cashflow statement for J B Chemicals and Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
C2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 3,489 | 5,969 | 5,049 | 5,552 | 7,515 |
Depreciation | |||||
Non-Cash Items | -584 | -1,148 | 297 | 814 | 489 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -811 | -2,359 | -4,371 | -1,254 | -1,381 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Accounts Payable | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 2,757 | 3,148 | 1,701 | 6,256 | 8,006 |
Capital Expenditures | -730 | -478 | -7,068 | -7,649 | -2,614 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 969 | -1,829 | 7,091 | -1,968 | -1,425 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 239 | -2,307 | 23.2 | -9,618 | -4,038 |
Financing Cash Flow Items | -18.6 | -63.5 | -24.6 | -378 | -442 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -3,061 | -874 | -1,384 | 3,565 | -3,855 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -63.9 | -32.8 | 341 | 204 | 113 |